ArticlePlant methods2025
Bioluminescent imaging of an oomycete pathogen empowers chemical selections and rational fungicide applications.
Article in Plant methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Fungicides play an indispensable role in ensuring food security. However, rational chemical selection and fungicide precision application guidance remain constrained by the limitations in real-time monitoring of tracking pathogens within plant tissues. In the current study, we generated a genetically stable Phytophthora infestans strain (PiLuc) expressing luciferase gene, which serves as a dual-mode quantification platform for both in vitro and in vivo throughput screening. Consequently, we designed a 96-well plate high-throughput screening system to assess compounds inhibitory efficacy using PiLuc. Crucially, bioluminescence imaging enabled visualization of PiLuc in potato leaves and tubers during early infection stage, which is invisible to the naked eye. Capitalizing on the semi non-destructive and visual advantages, we developed a system for fungicide bioavailability evaluation and dosage-response assessment in tuber tissues, integrating real-time dynamic monitoring of pathogen. The development of bioluminescent imaging of late blight pathogen establishes an enabling platform for high-throughput fungicide screening while improving the precision bioavailability assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.